Medical Imaging to improve decision making and maximise results
Medical imaging biomarkers can achieve substantial savings in both the time and costs associated with clinical development programmes. The use of medical imaging endpoints can enable the effects of new compounds to be determined at earlier stages of the clinical research process and provide important evidence to support go/no-go decision making compared with traditional endpoints such as clinical benefit or survival times.
Explore how including medical imaging biomarkers in the design of your trial can increase efficiency and improve your scientific data.
Contact us today for advice on how medical imaging can bring tangible benefits to your next study.